Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.91 |
| ▸ | MMP2 | P08253 | 1/20 | 0.91 |
| ▸ | THRB | P10828 | 1/20 | 0.91 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.91 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.91 |
| ▸ | OTC | P00480 | 1/20 | 0.50 |
| ▸ | TYMS | P04818 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Medronic Acid SCHEMBL17922880 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL4424564 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL8958446 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL27485770 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL5201705 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL6365875 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL1478332 | 1.00 | KDM4E (0.91) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL10843210 | 0.96 | KDM4E (0.83) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL27363300 | 0.96 | KDM4E (0.83) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Medronic Acid SCHEMBL66716 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9030008-B2 | Adhesion promoting composition for metal leadframes | CITIBANK, N.A. | 2015-05-12 | — | — | US | claimed |
| US-6395698-B1 | MIXTURE CONTAINING QUATERNARY AMMONIUM COMPOUND | MASON CHEMICAL COMPANY | 2002-05-28 | — | — | US | claimed |
| WO-2014041010-A1 | STABILIZATION OF PAINT STRIPPER FORMULATIONS | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2014-03-20 | — | — | WO | disclosed |
| EP-2683806-A1 | STABILIZATION OF SURFACTANTS AGAINST OXIDATIVE ATTACK | Akzo Nobel Chemicals International B.V. (NL) | 2014-01-15 | — | — | EP | disclosed |
| WO-2012123313-A1 | STABILIZATION OF SURFACTANTS AGAINST OXIDATIVE ATTACK | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2012-09-20 | — | — | WO | disclosed |
| US-20100249199-A1 | Hard Surface Treatment Compositions with Improved Mold or Fungi Remediation Properties | RECKITT & COLMAN (OVERSEAS) LIMITED (GB) | 2010-09-30 | — | — | US | disclosed |
| US-7488708-B2 | Foaming two-component hard surface cleaning compositions | RECKITT BENCKISER INC. (US) | 2009-02-10 | — | — | US | disclosed |
| US-20060276366-A1 | FOAMING TWO-COMPONENT HARD SURFACE CLEANING COMPOSITIONS | RECKITT BENCKISER INC. (US) | 2006-12-07 | — | — | US | disclosed |
| US-6395698-B1 | MIXTURE CONTAINING QUATERNARY AMMONIUM COMPOUND | MASON CHEMICAL COMPANY | 2002-05-28 | — | — | US | disclosed |
| US-4871652-A | CYANO SUBSTITUTED PHOTOGRAPHIC COUPLER | EASTMAN KODAK COMPANY (US) | 1989-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249199-A1 | Hard Surface Treatment Compositions with Improved Mold or Fungi Remediation Properties | DPM1, POLR1C, HAO2 | KDM4E 3189/4885MMP2 1705/4885THRB 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.